← FDA DRUG APPROVALS

FDA ANDA · ANDA062597

MYTREX F

Sponsor: SAVAGE LABS

APPLICATION
ANDA062597
TYPE
ANDA
ORIGINAL APPROVAL
1985-10-08
LATEST ACTION
1996-03-07
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

MYTREX FDiscontinued
NYSTATIN 100,000 UNITS/GM, TRIAMCINOLONE ACETONIDE 0.1% · CREAM · TOPICAL

Approval history

1996-03-07Manufacturing (CMC) · Supplement 3AP
1995-07-25Manufacturing (CMC) · Supplement 2AP
1994-04-25Labeling · Supplement 1AP
1985-10-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →